Turmeric - anti-nausea drug combo potent cancer killer Newstrack India Tweet | Washington, Aug 21 (ANI): A new study has found that anti-nausea drug thalidomide when combined with common kitchen spice turmeric creates hybrid molecules that effectively kills multiple myeloma cells. | Thalidomide was first introduced in the 1950s as an anti-nausea medication to help cont...
Incyte pancreatic cancer drug improves survival in mid-stage trial Sun Sentinel (Reuters) - Incyte Corp said a mid-stage trial of its experimental cancer treatment showed the drug, Jakafi, improved the survival rate of patients' most likely to benefit from the treatment. | The company's shares rose 20 percent in premarket trade....
Conventional and Indigenous Medicine Coordinated Work Defended All Africa [ANGOP]Huambo -The head of cultural heritage department of the central Huambo province, João Afonso, defended on Monday the need for having a coordinated and complementary work between the conventional and indigenous medicine, so as to improve the t...
Turmeric - anti-nausea drug combo potent cancer killer The Times Of India A new study has found that anti-nausea drug thalidomide when combined with common kitchen spice turmeric creates hybrid molecules that effectively kills multiple myeloma cells. | Thalidomide was first introduced in the 1950s as an anti-nausea medicat...
Peru drugs: UK pair charged with drug offences BBC News 21 August 2013 Last updated at 10:04 BST | Two women from the UK arrested in Peru on suspicion of drug smuggling have been charged and face a maximum sentence of 15 years if convicted. | Michaella McCollum, of Dungannon in Northern Ireland, and Melis...
50 per cent rise in disease that can kill babies The Daily Telegraph The number of babies contracting Group B streptococcal disease, one of the most severe infections that can strike infants, has risen by 50 per cent in... (photo: WN / Arturo Ubaub)
Roche not to pursue patent on breast cancer drug Herceptin The Hindu In a development that will bring some relief to breast cancer patients, Swiss drug-maker Roche has said that it will not pursue the patent on Trastuzu... (photo: WN/Patricia)
